[Chemotherapy and Radio-Chemotherapy of Locally Advanced Esophageal Cancer].

Chemotherapy and Radio-Chemotherapy of Locally Advanced Esophageal Cancer Surgical resection alone of locally advanced esophageal carcinoma leads to long-term survival in only about 30% of cases. The multimodal strategy for locally advanced tumors, especially neoadjuvant radiochemotherapy and chemotherapy, has significantly improved the long-term prognosis. Multimodal therapy concepts have been developed which improve overall survival.

[Curative Treatment of Esophageal Carcinoma - Disease, Diagnostics, Therapy in 2022].

Curative Treatment of Esophageal Carcinoma - Disease, Diagnostics, Therapy in 2022 Surgical resection remains the gold standard for non-metastatic carcinoma of the lower and middle third of the esophagus. Locally advanced tumors (T3) are pretreated neoadjuvantly (radiochemotherapy) or perioperatively (chemotherapy). A differentiated primary staging and an interdisciplinary case presentation are of essential importance today.